EGFR and carcinoma: UV-triggered drug release from nanoparticles provided chemo-, gene, and photodynamic therapy as a combination. The ROS levels were increased in cancer cells, and cell viability was reduced. Furthermore, external magnetic field application and anti-EGFR antibody provided active drug targeting in the carcinoma-bearing Balb/c nude mice and led efficient tumor reduction rate